Parejo-Alonso, B., Royo-García, A., Espiau-Romera, P., Courtois, S., Curiel-García, Á., Zagorac, S., Villaoslada, I., Olive, K. P., Heeschen, C., & Sancho, P. (2023). Pharmacological targeting of the receptor ALK inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinoma. Biomedicine & Pharmacotherapy, 158, 114162. https://doi.org/10.1016/j.biopha.2022.114162
Subjects:
Carcinoma, Pancreatic Ductal
(MeSH)
Pancreatic Neoplasms
(MeSH)
Pancreatic Cancer Research and Treatment
(OpenAlex Topic)
Cancer Stem Cells and Tumor Metastasis
(OpenAlex Topic)
Neuroblastoma Research and Treatment
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1016/j.biopha.2022.114162
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex